Global and Japan Vaccin Antirabic Market Insights, Forecast to 2027

Global and Japan Vaccin Antirabic Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Vaccin Antirabic Product Introduction
1.2 Market by Type
1.2.1 Global Vaccin Antirabic Market Size Growth Rate by Type
1.2.2 Gopher Kidney Cell Vaccine
1.2.3 Freeze-Dried Vero Cell Vaccine
1.2.4 Common Vero Cell Vaccines
1.2.5 Human Diploid Vaccine
1.3 Market by Application
1.3.1 Global Vaccin Antirabic Market Size Growth Rate by Application
1.3.2 Pre-exposure Prophylaxis
1.3.3 After Exposure Prophylaxis
1.3.4 Additional Doses
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccin Antirabic Market Size, Estimates and Forecasts
2.1.1 Global Vaccin Antirabic Revenue 2016-2027
2.1.2 Global Vaccin Antirabic Sales 2016-2027
2.2 Global Vaccin Antirabic, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Vaccin Antirabic Historical Market Size by Region (2016-2021)
2.3.1 Global Vaccin Antirabic Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Vaccin Antirabic Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Vaccin Antirabic Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Vaccin Antirabic Sales Forecast by Region (2022-2027)
2.4.2 Global Vaccin Antirabic Revenue Forecast by Region (2022-2027)
3 Global Vaccin Antirabic Competitor Landscape by Players
3.1 Global Top Vaccin Antirabic Manufacturers by Sales
3.1.1 Global Vaccin Antirabic Sales by Manufacturer (2016-2021)
3.1.2 Global Vaccin Antirabic Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Vaccin Antirabic Manufacturers by Revenue
3.2.1 Key Vaccin Antirabic Manufacturers Covered: Ranking by Revenue
3.2.2 Global Vaccin Antirabic Revenue by Manufacturers (2016-2021)
3.2.3 Global Vaccin Antirabic Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Vaccin Antirabic Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Vaccin Antirabic Revenue in 2020
3.2.6 Global Vaccin Antirabic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Vaccin Antirabic Price by Manufacturers
3.4 Global Vaccin Antirabic Manufacturing Base Distribution, Product Types
3.4.1 Vaccin Antirabic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vaccin Antirabic Product Type
3.4.3 Date of International Manufacturers Enter into Vaccin Antirabic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Vaccin Antirabic Market Size by Type (2016-2021)
4.1.1 Global Vaccin Antirabic Sales by Type (2016-2021)
4.1.2 Global Vaccin Antirabic Revenue by Type (2016-2021)
4.1.3 Vaccin Antirabic Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Vaccin Antirabic Market Size Forecast by Type (2022-2027)
4.2.1 Global Vaccin Antirabic Sales Forecast by Type (2022-2027)
4.2.2 Global Vaccin Antirabic Revenue Forecast by Type (2022-2027)
4.2.3 Vaccin Antirabic Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Vaccin Antirabic Market Size by Application (2016-2021)
5.1.1 Global Vaccin Antirabic Sales by Application (2016-2021)
5.1.2 Global Vaccin Antirabic Revenue by Application (2016-2021)
5.1.3 Vaccin Antirabic Price by Application (2016-2021)
5.2 Vaccin Antirabic Market Size Forecast by Application (2022-2027)
5.2.1 Global Vaccin Antirabic Sales Forecast by Application (2022-2027)
5.2.2 Global Vaccin Antirabic Revenue Forecast by Application (2022-2027)
5.2.3 Global Vaccin Antirabic Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Vaccin Antirabic Market Size YoY Growth 2016-2027
6.1.1 Japan Vaccin Antirabic Sales YoY Growth 2016-2027
6.1.2 Japan Vaccin Antirabic Revenue YoY Growth 2016-2027
6.1.3 Japan Vaccin Antirabic Market Share in Global Market 2016-2027
6.2 Japan Vaccin Antirabic Market Size by Players (International and Local Players)
6.2.1 Japan Top Vaccin Antirabic Players by Sales (2016-2021)
6.2.2 Japan Top Vaccin Antirabic Players by Revenue (2016-2021)
6.3 Japan Vaccin Antirabic Historic Market Review by Type (2016-2021)
6.3.1 Japan Vaccin Antirabic Sales Market Share by Type (2016-2021)
6.3.2 Japan Vaccin Antirabic Revenue Market Share by Type (2016-2021)
6.3.3 Japan Vaccin Antirabic Price by Type (2016-2021)
6.4 Japan Vaccin Antirabic Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Vaccin Antirabic Sales Forecast by Type (2022-2027)
6.4.2 Japan Vaccin Antirabic Revenue Forecast by Type (2022-2027)
6.4.3 Japan Vaccin Antirabic Price Forecast by Type (2022-2027)
6.5 Japan Vaccin Antirabic Historic Market Review by Application (2016-2021)
6.5.1 Japan Vaccin Antirabic Sales Market Share by Application (2016-2021)
6.5.2 Japan Vaccin Antirabic Revenue Market Share by Application (2016-2021)
6.5.3 Japan Vaccin Antirabic Price by Application (2016-2021)
6.6 Japan Vaccin Antirabic Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Vaccin Antirabic Sales Forecast by Application (2022-2027)
6.6.2 Japan Vaccin Antirabic Revenue Forecast by Application (2022-2027)
6.6.3 Japan Vaccin Antirabic Price Forecast by Application (2022-2027)
7 North America
7.1 North America Vaccin Antirabic Market Size YoY Growth 2016-2027
7.2 North America Vaccin Antirabic Market Facts & Figures by Country
7.2.1 North America Vaccin Antirabic Sales by Country (2016-2021)
7.2.2 North America Vaccin Antirabic Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Vaccin Antirabic Market Size YoY Growth 2016-2027
8.2 Asia Pacific Vaccin Antirabic Market Facts & Figures by Region
8.2.1 Asia Pacific Vaccin Antirabic Sales by Region (2016-2021)
8.2.2 Asia Pacific Vaccin Antirabic Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Vaccin Antirabic Market Size YoY Growth 2016-2027
9.2 Europe Vaccin Antirabic Market Facts & Figures by Country
9.2.1 Europe Vaccin Antirabic Sales by Country (2016-2021)
9.2.2 Europe Vaccin Antirabic Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Vaccin Antirabic Market Size YoY Growth 2016-2027
10.2 Latin America Vaccin Antirabic Market Facts & Figures by Country
10.2.1 Latin America Vaccin Antirabic Sales by Country (2016-2021)
10.2.2 Latin America Vaccin Antirabic Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Vaccin Antirabic Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Vaccin Antirabic Market Facts & Figures by Country
11.2.1 Middle East and Africa Vaccin Antirabic Sales by Country (2016-2021)
11.2.2 Middle East and Africa Vaccin Antirabic Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Vaccin Antirabic Products Offered
12.1.5 GSK Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi Vaccin Antirabic Products Offered
12.2.5 Sanofi Recent Development
12.3 Chengda
12.3.1 Chengda Corporation Information
12.3.2 Chengda Description and Business Overview
12.3.3 Chengda Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Chengda Vaccin Antirabic Products Offered
12.3.5 Chengda Recent Development
12.4 Yisheng
12.4.1 Yisheng Corporation Information
12.4.2 Yisheng Description and Business Overview
12.4.3 Yisheng Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Yisheng Vaccin Antirabic Products Offered
12.4.5 Yisheng Recent Development
12.5 Merck
12.5.1 Merck Corporation Information
12.5.2 Merck Description and Business Overview
12.5.3 Merck Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Merck Vaccin Antirabic Products Offered
12.5.5 Merck Recent Development
12.6 VACN
12.6.1 VACN Corporation Information
12.6.2 VACN Description and Business Overview
12.6.3 VACN Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.6.4 VACN Vaccin Antirabic Products Offered
12.6.5 VACN Recent Development
12.7 Changsheng
12.7.1 Changsheng Corporation Information
12.7.2 Changsheng Description and Business Overview
12.7.3 Changsheng Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Changsheng Vaccin Antirabic Products Offered
12.7.5 Changsheng Recent Development
12.8 BCHT
12.8.1 BCHT Corporation Information
12.8.2 BCHT Description and Business Overview
12.8.3 BCHT Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.8.4 BCHT Vaccin Antirabic Products Offered
12.8.5 BCHT Recent Development
12.9 Hissen
12.9.1 Hissen Corporation Information
12.9.2 Hissen Description and Business Overview
12.9.3 Hissen Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hissen Vaccin Antirabic Products Offered
12.9.5 Hissen Recent Development
12.10 Zhongke Biological
12.10.1 Zhongke Biological Corporation Information
12.10.2 Zhongke Biological Description and Business Overview
12.10.3 Zhongke Biological Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Zhongke Biological Vaccin Antirabic Products Offered
12.10.5 Zhongke Biological Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Vaccin Antirabic Products Offered
12.11.5 GSK Recent Development
12.12 Guangzhou Nuocheng Biological
12.12.1 Guangzhou Nuocheng Biological Corporation Information
12.12.2 Guangzhou Nuocheng Biological Description and Business Overview
12.12.3 Guangzhou Nuocheng Biological Vaccin Antirabic Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Guangzhou Nuocheng Biological Products Offered
12.12.5 Guangzhou Nuocheng Biological Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Vaccin Antirabic Industry Trends
13.2 Vaccin Antirabic Market Drivers
13.3 Vaccin Antirabic Market Challenges
13.4 Vaccin Antirabic Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vaccin Antirabic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Vaccin Antirabic Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Gopher Kidney Cell Vaccine
Table 3. Major Manufacturers of Freeze-Dried Vero Cell Vaccine
Table 4. Major Manufacturers of Common Vero Cell Vaccines
Table 5. Major Manufacturers of Human Diploid Vaccine
Table 6. Global Vaccin Antirabic Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Vaccin Antirabic Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Vaccin Antirabic Sales by Regions (2016-2021) & (K Units)
Table 9. Global Vaccin Antirabic Sales Market Share by Regions (2016-2021)
Table 10. Global Vaccin Antirabic Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Vaccin Antirabic Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Vaccin Antirabic Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Vaccin Antirabic Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Vaccin Antirabic Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Vaccin Antirabic Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Vaccin Antirabic Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Vaccin Antirabic Manufacturers by Revenue (US$ Million) in 2020
Table 18. Vaccin Antirabic Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Vaccin Antirabic Revenue Share by Manufacturers (2016-2021)
Table 20. Global Vaccin Antirabic Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Vaccin Antirabic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccin Antirabic as of 2020)
Table 22. Key Manufacturers Vaccin Antirabic Price (2016-2021) (US$/Unit)
Table 23. Vaccin Antirabic Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Vaccin Antirabic Product Type
Table 25. Date of International Manufacturers Enter into Vaccin Antirabic Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Vaccin Antirabic Sales by Type (2016-2021) (K Units)
Table 28. Global Vaccin Antirabic Sales Share by Type (2016-2021)
Table 29. Global Vaccin Antirabic Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Vaccin Antirabic Revenue Share by Type (2016-2021)
Table 31. Vaccin Antirabic Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 32. Global Vaccin Antirabic Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Vaccin Antirabic Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Vaccin Antirabic Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Vaccin Antirabic Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Vaccin Antirabic Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Vaccin Antirabic Sales by Application (2016-2021) (K Units)
Table 38. Global Vaccin Antirabic Sales Share by Application (2016-2021)
Table 39. Global Vaccin Antirabic Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Vaccin Antirabic Revenue Share by Application (2016-2021)
Table 41. Vaccin Antirabic Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 42. Global Vaccin Antirabic Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Vaccin Antirabic Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Vaccin Antirabic Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Vaccin Antirabic Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Vaccin Antirabic Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 47. Japan Vaccin Antirabic Sales (K Units) of Key Companies (2016-2021)
Table 48. Japan Vaccin Antirabic Sales Share by Company (2016-2021)
Table 49. Japan Vaccin Antirabic Revenue (US$ Million) by Company (2016-2021)
Table 50. Japan Vaccin Antirabic Revenue Share by Company (2016-2021)
Table 51. Japan Vaccin Antirabic Sales (K Units) by Type (2016-2021)
Table 52. Japan Vaccin Antirabic Sales Share by Type (2016-2021)
Table 53. Japan Vaccin Antirabic Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. Japan Vaccin Antirabic Price (US$/Unit) by Type (2016-2021)
Table 55. Japan Vaccin Antirabic Sales (K Units) by Type (2022-2027)
Table 56. Japan Vaccin Antirabic Sales Share by Type (2022-2027)
Table 57. Japan Vaccin Antirabic Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. Japan Vaccin Antirabic Revenue Share by Type (2022-2027)
Table 59. Japan Vaccin Antirabic Price (US$/Unit) by Type (2022-2027)
Table 60. Japan Vaccin Antirabic Sales (K Units) by Application (2016-2021)
Table 61. Japan Vaccin Antirabic Sales Share by Application (2016-2021)
Table 62. Japan Vaccin Antirabic Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. Japan Vaccin Antirabic Price (US$/Unit) by Application (2016-2021)
Table 64. Japan Vaccin Antirabic Sales (K Units) by Application (2022-2027)
Table 65. Japan Vaccin Antirabic Sales Share by Application (2022-2027)
Table 66. Japan Vaccin Antirabic Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. Japan Vaccin Antirabic Revenue Share by Application (2022-2027)
Table 68. Japan Vaccin Antirabic Price (US$/Unit) by Application (2022-2027)
Table 69. North America Vaccin Antirabic Sales by Country (2016-2021) & (K Units)
Table 70. North America Vaccin Antirabic Sales Market Share by Country (2016-2021)
Table 71. North America Vaccin Antirabic Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Vaccin Antirabic Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Vaccin Antirabic Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Vaccin Antirabic Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Vaccin Antirabic Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Vaccin Antirabic Revenue Market Share by Region (2016-2021)
Table 77. Europe Vaccin Antirabic Sales by Country (2016-2021) & (K Units)
Table 78. Europe Vaccin Antirabic Sales Market Share by Country (2016-2021)
Table 79. Europe Vaccin Antirabic Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Vaccin Antirabic Revenue Market Share by Country (2016-2021)
Table 81. Latin America Vaccin Antirabic Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Vaccin Antirabic Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Vaccin Antirabic Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Vaccin Antirabic Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Vaccin Antirabic Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Vaccin Antirabic Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Vaccin Antirabic Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Vaccin Antirabic Revenue Market Share by Country (2016-2021)
Table 89. GSK Corporation Information
Table 90. GSK Description and Business Overview
Table 91. GSK Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 92. GSK Vaccin Antirabic Product
Table 93. GSK Recent Development
Table 94. Sanofi Corporation Information
Table 95. Sanofi Description and Business Overview
Table 96. Sanofi Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 97. Sanofi Product
Table 98. Sanofi Recent Development
Table 99. Chengda Corporation Information
Table 100. Chengda Description and Business Overview
Table 101. Chengda Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 102. Chengda Product
Table 103. Chengda Recent Development
Table 104. Yisheng Corporation Information
Table 105. Yisheng Description and Business Overview
Table 106. Yisheng Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 107. Yisheng Product
Table 108. Yisheng Recent Development
Table 109. Merck Corporation Information
Table 110. Merck Description and Business Overview
Table 111. Merck Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 112. Merck Product
Table 113. Merck Recent Development
Table 114. VACN Corporation Information
Table 115. VACN Description and Business Overview
Table 116. VACN Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 117. VACN Product
Table 118. VACN Recent Development
Table 119. Changsheng Corporation Information
Table 120. Changsheng Description and Business Overview
Table 121. Changsheng Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 122. Changsheng Product
Table 123. Changsheng Recent Development
Table 124. BCHT Corporation Information
Table 125. BCHT Description and Business Overview
Table 126. BCHT Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 127. BCHT Product
Table 128. BCHT Recent Development
Table 129. Hissen Corporation Information
Table 130. Hissen Description and Business Overview
Table 131. Hissen Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 132. Hissen Product
Table 133. Hissen Recent Development
Table 134. Zhongke Biological Corporation Information
Table 135. Zhongke Biological Description and Business Overview
Table 136. Zhongke Biological Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 137. Zhongke Biological Product
Table 138. Zhongke Biological Recent Development
Table 139. Ningbo Rongan Biological Pharmaceutical Corporation Information
Table 140. Ningbo Rongan Biological Pharmaceutical Description and Business Overview
Table 141. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 142. Ningbo Rongan Biological Pharmaceutical Product
Table 143. Ningbo Rongan Biological Pharmaceutical Recent Development
Table 144. Guangzhou Nuocheng Biological Corporation Information
Table 145. Guangzhou Nuocheng Biological Description and Business Overview
Table 146. Guangzhou Nuocheng Biological Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Guangzhou Nuocheng Biological Product
Table 148. Guangzhou Nuocheng Biological Recent Development
Table 149. Vaccin Antirabic Market Trends
Table 150. Vaccin Antirabic Market Drivers
Table 151. Vaccin Antirabic Market Challenges
Table 152. Vaccin Antirabic Market Restraints
Table 153. Vaccin Antirabic Customers List
Table 154. Vaccin Antirabic Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccin Antirabic Product Picture
Figure 2. Global Vaccin Antirabic Sales Market Share by Type in 2020 & 2027
Figure 3. Gopher Kidney Cell Vaccine Product Picture
Figure 4. Freeze-Dried Vero Cell Vaccine Product Picture
Figure 5. Common Vero Cell Vaccines Product Picture
Figure 6. Human Diploid Vaccine Product Picture
Figure 7. Global Vaccin Antirabic Sales Market Share by Application in 2020 & 2027
Figure 8. Pre-exposure Prophylaxis
Figure 9. After Exposure Prophylaxis
Figure 10. Additional Doses
Figure 11. Vaccin Antirabic Report Years Considered
Figure 12. Global Vaccin Antirabic Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Vaccin Antirabic Market Size 2016-2027 (US$ Million)
Figure 14. Global Vaccin Antirabic Sales 2016-2027 (K Units)
Figure 15. Global Vaccin Antirabic Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Vaccin Antirabic Sales Market Share by Region (2016-2021)
Figure 17. Global Vaccin Antirabic Sales Market Share by Region in 2020
Figure 18. Global Vaccin Antirabic Revenue Market Share by Region (2016-2021)
Figure 19. Global Vaccin Antirabic Revenue Market Share by Region in 2020
Figure 20. Global Vaccin Antirabic Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Vaccin Antirabic Revenue in 2020
Figure 22. Vaccin Antirabic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Vaccin Antirabic Sales Market Share by Type (2016-2021)
Figure 24. Global Vaccin Antirabic Sales Market Share by Type in 2020
Figure 25. Global Vaccin Antirabic Revenue Market Share by Type (2016-2021)
Figure 26. Global Vaccin Antirabic Revenue Market Share by Type in 2020
Figure 27. Global Vaccin Antirabic Sales Market Share by Application (2016-2021)
Figure 28. Global Vaccin Antirabic Sales Market Share by Application in 2020
Figure 29. Global Vaccin Antirabic Revenue Market Share by Application (2016-2021)
Figure 30. Global Vaccin Antirabic Revenue Market Share by Application in 2020
Figure 31. Japan Vaccin Antirabic Sales Growth Rate 2016-2027 (K Units)
Figure 32. Japan Vaccin Antirabic Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Japan Vaccin Antirabic Market Share in Global Market 2016-2027
Figure 34. Japan 5 and 10 Largest Vaccin Antirabic Players Market Share by Revenue in Vaccin Antirabic in 2020
Figure 35. Japan Vaccin Antirabic Revenue Share by Type (2016-2021)
Figure 36. Japan Vaccin Antirabic Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Japan Vaccin Antirabic Revenue Share by Application (2016-2021)
Figure 38. Japan Vaccin Antirabic Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Vaccin Antirabic Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Vaccin Antirabic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Vaccin Antirabic Sales Market Share by Country in 2020
Figure 42. North America Vaccin Antirabic Revenue Market Share by Country in 2020
Figure 43. U.S. Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 44. U.S. Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Vaccin Antirabic Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe Vaccin Antirabic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Vaccin Antirabic Sales Market Share by Country in 2020
Figure 50. Europe Vaccin Antirabic Revenue Market Share by Country in 2020
Figure 51. Germany Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 54. France Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 56. U.K. Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 60. Russia Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Vaccin Antirabic Sales Growth Rate 2016-2021 (K Units)
Figure 62. Asia Pacific Vaccin Antirabic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Vaccin Antirabic Sales Market Share by Region in 2020
Figure 64. Asia Pacific Vaccin Antirabic Revenue Market Share by Region in 2020
Figure 65. China Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 66. China Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 68. Japan Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 70. South Korea Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 72. India Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 74. Australia Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 76. Taiwan Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 78. Indonesia Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 80. Thailand Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 82. Malaysia Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 84. Philippines Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 86. Vietnam Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Vaccin Antirabic Sales Growth Rate 2016-2021 (K Units)
Figure 88. Latin America Vaccin Antirabic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Vaccin Antirabic Sales Market Share by Country in 2020
Figure 90. Latin America Vaccin Antirabic Revenue Market Share by Country in 2020
Figure 91. Mexico Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 92. Mexico Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 94. Brazil Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 96. Argentina Vaccin Antirabic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Vaccin Antirabic Sales Growth Rate 2016-2021 (K Units)
Figure 98. Middle East and Africa Vaccin Antirabic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Vaccin Antirabic Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Vaccin Antirabic Revenue Market Share by Country in 2020
Figure 101. Turkey Vaccin Antirabic Sales Growth Rate (2016-2021) (K Units)
Figure 102. Turkey Vaccin Antirabic Revenue Growth Rate (2016-2021) (U

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs